GLP-1RA in the Real World
1-year semaglutide compliance is low at 56.4%. 1-year TWL for all patients prescribed semaglutide was 8.8%, and 10.9% for those who took semaglutide for 1 complete year. Patients who underwent RYGB tended to lose more weight with semaglutide than naïve MBS patients.
Authors
- Vasundhara Mathur (ORCID: https://orcid.org/0000-0002-6395-750X)
- Abdelrahman Ali Nimeri (ORCID: https://orcid.org/0000-0001-7844-163X)
- Thomas H. Shin (ORCID: https://orcid.org/0000-0003-2076-270X)
- Pourya Medhati (ORCID: https://orcid.org/0000-0001-6684-3439)
- Ali Tavakkoli (ORCID: https://orcid.org/0000-0002-7430-1848)
- Eric G. Sheu (ORCID: https://orcid.org/0000-0003-2707-1768)
- Katherine Wasden
- Caroline M. Apovian
Institutions
- Brigham and Women's Hospital (US)
- Dartmouth–Hitchcock Medical Center (US)
- University of Virginia (US)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1097/sla.0000000000006748
- Citations
- 10
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 12.95